BRIEF published on 12/12/2024 at 21:35, 1 year 3 months ago Medincell Joins Euronext SBF 120 Index Market Capitalization Medincell CAC 40 Euronext SBF 120 Financial Visibility
PRESS RELEASE published on 12/12/2024 at 21:30, 1 year 3 months ago Inside Information / Other news releases Medincell joins Euronext SBF 120 & CAC Mid 60 indices, enhancing visibility and investor appeal. Market capitalization-based indices by Euronext. Effective inclusion from Dec 20 Market Capitalization Medincell Index Inclusion Euronext SBF 120 CAC Mid 60
BRIEF published on 11/28/2024 at 18:45, 1 year 3 months ago Medincell Announces Video Conference for Half-Year Results Half-year Results Schizophrenia Medincell Videoconference BEPO Technology
BRIEF published on 11/22/2024 at 18:05, 1 year 4 months ago MedinCell: Update of share capital and voting rights Share Capital Voting Rights Euronext Actions Medincell
BRIEF published on 11/06/2024 at 13:47, 1 year 4 months ago Medincell: 2024 revenues on the rise and significant clinical progress Clinical Trial Revenue Projections Medincell Olanzapine LAI UZEDY
PRESS RELEASE published on 11/06/2024 at 13:42, 1 year 4 months ago Inside Information / Other news releases Medincell achieves 25% increase in 2024 UZEDY® revenue outlook reaching $100M and key milestone in Olanzapine LAI Phase 3 clinical trials. Teva Pharmaceuticals shares Q3 results Revenue Clinical Trials Medincell Teva Pharmaceuticals UZEDY
BRIEF published on 10/01/2024 at 15:47, 1 year 5 months ago Threshold crossing by Mirova in MEDINCELL Capital Actions Threshold Crossing Medincell Mirova
BRIEF published on 09/24/2024 at 11:54, 1 year 6 months ago Teva and Medincell Present Promising Results on Olanzapine LAI for Schizophrenia Clinical Trial Schizophrenia Medincell Teva Olanzapine LAI
PRESS RELEASE published on 09/24/2024 at 11:53, 1 year 6 months ago Inside Information / Other news releases Teva and Medincell reveal positive efficacy, safety, and tolerability data from Phase 3 study on Olanzapine LAI for schizophrenia treatment, presenting at ECNP 2024 Schizophrenia Treatment Phase 3 Study Medincell Teva Olanzapine LAI
BRIEF published on 09/18/2024 at 10:13, 1 year 6 months ago Mirova crosses the threshold of 5% of voting rights in MEDINCELL Voting Rights Actions Threshold Crossing Medincell Mirova
Published on 03/28/2026 at 01:00, 6 hours 21 minutes ago Battery X Metals Announces Confidential Submission of Amended Draft Registration Statement with the U.S. Securities and Exchange Commission in Connection with Proposed U.S. National Securities Exchange Initial Public Offering
Published on 03/28/2026 at 00:55, 6 hours 26 minutes ago Notification of Relevant Change to Significant Shareholder
Published on 03/28/2026 at 00:50, 6 hours 31 minutes ago "Rise" Selected as NASA Artemis II Moon Mascot
Published on 03/27/2026 at 22:45, 8 hours 36 minutes ago Caledonia Mining Corporation Plc - Notification of Relevant Change to Significant Shareholder
Published on 03/27/2026 at 22:30, 8 hours 51 minutes ago Usha Resources Completes Extended Induced Polarization Survey at the Southern Arm Property
Published on 03/28/2026 at 01:42, 5 hours 39 minutes ago EQS-Adhoc: Raiffeisen Bank International AG: Agreement on the acquisition of Garanti BBVA Group Romania
Published on 03/27/2026 at 21:58, 9 hours 23 minutes ago Kaufman & Broad SA: Availability of the Universal Registration Document 2025
Published on 03/27/2026 at 20:08, 11 hours 13 minutes ago EQS-Adhoc: CECONOMY AG: Information on the ongoing public takeover process – uncertainty regarding FDI clearance in Austria
Published on 03/27/2026 at 19:30, 11 hours 51 minutes ago Turning Potential into Reality: Future 500 Ignites Scale-Up Momentum in Europe
Published on 03/27/2026 at 19:30, 11 hours 51 minutes ago FONDAZIONE MAIRE PRESENTED IN BERLIN THE "CLIMATE GOALS" STUDY IN THE FRAMEWORK OF MAIRE EUROPEAN STRATEGY LEVERAGING ON GERMANY
Published on 03/27/2026 at 18:52, 12 hours 29 minutes ago Crédit Agricole CIB announces the publication of its 2025 Universal Registration Document
Published on 03/27/2026 at 18:40, 12 hours 41 minutes ago 2026 share capital increase reserved for members of the Saint-Gobain Group employee savings plan
Published on 03/27/2026 at 17:53, 13 hours 28 minutes ago Publication of Carrefour's 2025 Universal Registration Document
Published on 03/27/2026 at 17:45, 13 hours 36 minutes ago PUBLICATION OF THE UNIVERSAL REGISTRATION DOCUMENT FISCAL YEAR 2025
